about
National trends in psychotropic medication use in young children: 1994-2009Variability in ADHD care in community-based pediatricsAssociation of attention-deficit/hyperactivity disorder and conduct disorder with early tobacco and alcohol useRelationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.Understanding treatment decision making in juvenile idiopathic arthritis: a qualitative assessment.Shared decision making for hydroxyurea treatment initiation in children with sickle cell anemia.Oral antibiotics at discharge for children with acute osteomyelitis: a rapid cycle improvement project.Impact of a Web-Portal Intervention on Community ADHD Care and OutcomesImpact of Mental Health Comorbidities on the Community-Based Pediatric Treatment and Outcomes of Children with Attention Deficit Hyperactivity Disorder.Multimodal Treatment of the School-aged Child With Attention-Deficit/Hyperactivity Disorder.Reasons Why Children and Adolescents With Attention-Deficit/Hyperactivity Disorder Stop and Restart Taking Medicine.Consideration of Insulin Pumps or Continuous Glucose Monitors by Adolescents With Type 1 Diabetes and Their Parents: Stakeholder Engagement in the Design of Web-Based Decision Aids.Sluggish Cognitive Tempo as a Possible Predictor of Methylphenidate Response in Children With ADHD: A Randomized Controlled Trial.Electronically Verified Use of Internet-Based, Multimedia Decision Aids by Adolescents With Type 1 Diabetes and Their CaregiversPredictors of Medication Continuity in Children With ADHDAdolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional PreferencesDevelopment of a Hydroxyurea Decision Aid for Parents of Children With Sickle Cell AnemiaAttention-Deficit/Hyperactivity Disorder-Related Deficits and Psychostimulant Medication Effects on Comprehension of Audiovisually Presented Educational Material in ChildrenGuideline Adoption for Community-Acquired Pneumonia in the Outpatient SettingFactors Associated with Attention Deficit Hyperactivity Disorder Medication Use in Community Care SettingsPre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder
P50
Q33819699-BD4A310D-D471-45C3-A593-E4D19D3B9E7FQ34567723-8F22BB3B-68CA-4A4C-B86F-286DAE5B6594Q34980273-20FF0733-44DE-4AC1-852E-FE753AF25E1FQ36731199-6E630BFB-A69F-4E22-B87E-FD2DBB795BD2Q37361905-667E5680-0D1E-4622-BB0C-CC11B3E55674Q37612822-DF92D183-CAA4-49A2-B6FF-68A85A32508DQ38172083-74FCDF0D-2860-4BAA-884C-22A0E599A724Q42234646-8EE061B1-F5A4-47B7-83D7-A218BF426379Q45047987-A4DC2091-DB12-47B2-A921-A1774EC2E127Q47195838-B808FC27-B016-4A63-B611-79A6E4DDCE05Q47690768-9B009220-2084-4EFA-B41E-C9E5758B581CQ48616821-6EC63D02-7B51-4800-8AE3-CDEF92D9C339Q50421581-3C263F40-762C-468B-A0DE-811831AC8DE4Q57146219-3DE92B5E-0267-492A-84F7-542121C0BF4BQ88793391-AF7677ED-31E3-4BBD-949F-7C22F8696F43Q88880563-2C479683-8465-4437-8CF5-7865104362C7Q90464611-0F208115-7298-4665-9B77-86563480703CQ91156841-E72FD8C5-5D16-4995-8A20-7F0A268E6C86Q91734721-76C2463D-63DB-4ECC-BE40-53821F203EA4Q91837898-FDEF7610-2E66-4063-BB42-4D8E47947EDFQ92007440-34BAB235-5C5A-4B2F-88A0-423C5C25AD70
P50
description
researcher
@en
wetenschapper
@nl
name
William B Brinkman
@en
William B Brinkman
@nl
type
label
William B Brinkman
@en
William B Brinkman
@nl
prefLabel
William B Brinkman
@en
William B Brinkman
@nl
P31
P496
0000-0003-3336-7637